Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution 29.08.2024, 19:00 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Medacta Group 157,70 EUR -1,25 % Lang & Schwarz

Medacta Group SA / Key word(s): Partnership
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

29.08.2024 / 19:00 CET/CEST


MEDIA RELEASE

Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

CASTEL SAN PIETRO, 29 August 2024 - Medacta Group SA (“Medacta”, SIX:MOVE), announces its partnership with THINK Surgical®, an innovative leader in the field of open platform orthopedic robots, to provide its robotic, wireless hand-held TMINI® Miniature Robotic System for total knee replacement surgery supporting both GMK Sphere and GMK SpheriKA, the world’s first knee implant designed specifically for Kinematic Alignment, a personalized and innovative technique that significantly increases patient satisfaction and facilitates a return to a healthy, active life1.

“I am pleased to announce our collaboration with THINK Surgical in the US Market,” stated Matt Goudy, Managing Director and President of Medacta USA. “This partnership marks another step forward in our commitment to offering cutting-edge technologies that drive sustainable innovation forward and enhance our ability to deliver personalized solutions for surgeons and patients worldwide.”

The THINK Surgical TMINI system, when combined with GMK Sphere and GMK SpheriKA, adds further value to MyKA, the most comprehensive platform to safely and reproducibly perform Kinematic Alignment total knee replacement. Moreover, it complements the Medacta portfolio of enabling technologies designed for knee arthroplasty, providing surgeons with a robotic-assisted  option to execute meticulous 3D CT-based preoperative planning. This system will complement the MySolutions Personalized Ecosystem, a network of advanced digital solutions designed to improve patient outcomes and healthcare efficiency during the entire episode of care. This includes the flagship NextAR Augmented Reality Surgical Platform, a unique system that leverages patient-specific data to complement operative workflows, as well as MyKnee Patient Matched Technology and Efficiency KneePack, which is successfully used to provide patient-specific cutting blocks, single-use instrumentation, and implants in a single, one-time use kit.

While the MySolutions Ecosystem remains central to Medacta’s technology focus, the partnership with THINK Surgical will allow for the continued evaluation of robotics in the U.S. market, as well as Medacta’s specialized focus in the rapidly growing Ambulatory Surgery Center segment, in particular.

All Medacta products are supported by the comprehensive, tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education with personalized, high-level educational pathways. With Medacta, the surgeon is never alone while discovering new technologies.

Contact

Medacta International SA
Gianluca Olgiati     
Group Vice President Marketing  
Phone: +41 91 696 60 60
media@medacta.ch

About Medacta

Medacta is a key global player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta TVYouTubeLinkedIn and X.

RELATED TRADEMARKS

Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts. MySolutions™ Personalized Ecosystem, NextAR™, GMK® SpheriKA, GMK® Sphere, MyKA™, MyKnee®.

THINK Surgical® and TMINI® are trademarks of THINK Surgical, Inc.

REFERENCE

[1] Niki Y, Nagura T, Kobayashi S, Udagawa K, Harato K. Who Will Benefit From Kinematically Aligned Total Knee Arthroplasty? Perspectives on Patient-Reported Outcome Measures. J Arthroplasty. 2020 Feb;35(2):438-442.e2. doi: 10.1016/j.arth.2019.09.035. Epub 2019 Sep 26. PMID: 31668528.


Additional features:

File: Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution


End of Media Release


Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 1977995

 
End of News EQS News Service

1977995  29.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1977995&application_name=news&site_id=boersennews_de~~~d41e2cc8-bdcb-47ba-bb51-c77a04513666
Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer